**Core Concept**
Myoclonus in children refers to sudden, brief, shock-like muscle contractions, often requiring pharmacological management. The underlying principle involves modifying neurotransmitter levels or receptor activity to reduce muscle spasms. **Neurotransmitters** like serotonin, GABA, and glycine play crucial roles in regulating muscle tone.

**Why the Correct Answer is Right**
Since the correct answer options are not provided, a general approach to treating myoclonus involves using medications that enhance **GABA** activity, given GABA's role as an inhibitory neurotransmitter. Drugs like **valproate** or **clonazepam** can be effective by either increasing GABA levels or mimicking its action, thus reducing the frequency of myoclonic jerks.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option, a common incorrect choice might involve using a medication that could potentially worsen myoclonus, such as certain **antidepressants** that can sometimes exacerbate the condition.
**Option B:** Another incorrect option might be a drug that is not typically used for myoclonus, such as a **beta-blocker**, which is more commonly used for cardiovascular diseases.
**Option C:** This could involve a medication with a different primary use, like an **antihistamine**, which is not a first-line treatment for myoclonus.
**Option D:** Similarly, an incorrect option could be a drug that is not primarily used for neurological conditions, such as a **corticosteroid**, which, although used in some neurological conditions, is not the first choice for myoclonus.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that myoclonus can be a symptom of various underlying conditions, including **epileptic syndromes**, **infectious diseases**, or **metabolic disorders**. Thus, treating the underlying cause is crucial.

**Correct Answer:** D. Levetiracetam.